Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Perfusion Imaging Market Research Report - Global Forecast till 2024
Global Perfusion Imaging Market: Information by Modality (Computed Tomography (CT Scan), Magnetic Resonance Imaging (MRI) and Nuclear Medicine), Application (Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging and others) and Region - Forecast till 2024
Market Analysis:
To reach USD 7,745.57 Million by the year 2024, the Global Perfusion Imaging Market is anticipated to record a CAGR of 6.34% . Perfusion imaging is a non-invasive imaging test that demonstrates how the blood flows through the organs or tissues. This test is used for the diagnosis of various chronic disorders. Growing prevalence of cardiovascular & neurological diseases, rising geriatric population, and improvements in technology are pushing the growth of the global perfusion imaging market. However, stringent regulatory policies are prone to hinder the market growth. Growing incidence of cardiovascular & neurological diseases and increasing geriatric population are pushing the evolution of the global perfusion imaging market. As, as per the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, in the year 2017, every year about 795,000 people in the US have a hit in which about 610,000 of them are first, or new strokes and185,000 are recurrent strokes. Furthermore, innovations in technology are further stimulating market growth. In the year 2019, January Shimadzu Corporation bought Core Medical Imaging, Inc. to improve its healthcare business in North America. This procurement boosted the company’s foothold in the North American market. In March, 2018 GE received approval from Health Canada for Signa Premier, a 3.0T MRI system. This increased the product portfolio of the company. Australia held a share of 11.2% in the Asia-Pacific perfusion imaging market in 2018. Also, the market in the Middle East & Africa is expected to steadily grow owing to the increasing awareness about diseases in the region.
Market Segmentation:
Global Perfusion Imaging Market has been segmented by Modality, by application, and by region. Based on Modality the market is divided into Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI) and Nuclear Medicine. Based on application the market is divided into Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging, and Others. Based on region the market has been divided into various regions like Americas including US & Canada from North America and Latin America, Europe including Western Europe(Germany, UK, France, Italy, Spain, Rest of Western Europe and Eastern Europe), Asia-Pacific including China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific, and Middle East & Africa.
Regional Analysis:
The Global Perfusion Imaging Market has been distributed into several counties like Americas including US & Canada from North America and Latin America, Europe including Western Europe(Germany, UK, France, Italy, Spain, Rest of Western Europe and Eastern Europe), Asia-Pacific including China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific, and Middle East & Africa. The largest share of the global perfusion imaging market is expected to held by America.This is remaining to the rising rate of cardiovascular diseases, brain tumors, and tumor-related angiogenesis, among others, in the region. Europe showed a considerable amount of evolution in the market due to the rising prevalence of neurological disorders. Asia-Pacific is expected to be the quickest rising region in the global market due to the huge geriatric population and the presence of rapidly developing economies such as China, India, and South Korea.
Key Players:
The major companies functioning in the Global Perfusion Imaging Market are concentrating on firming their global ways by entering into untouched markets. Siemens (Germany), Bracco Diagnostic, Koninklijke Philips NV (Netherlands), lantheus Medical Imaging, Inc. (US), Shimadzu Corporation (Japan), Perimed (US), General Electric Company (US), Medtronic (Ireland), Inc. (Italy), Neusoft Corporation (China), Canon Medical Systems Corporation (Japan), Aetna (US), Advantis Medical Imaging (Netherland), and others are some of the major players in the Global Perfusion Imaging Market .The projected onlookers in the Global EMS and ODM Market are Hospitals Medical devices companies, Research institutes, Contract Research Organizations and Academic institutes.
Global Perfusion Imaging Market: Information by Modality (Computed Tomography (CT Scan), Magnetic Resonance Imaging (MRI) and Nuclear Medicine), Application (Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging and others) and Region - Forecast till 2024
Market Analysis:
To reach USD 7,745.57 Million by the year 2024, the Global Perfusion Imaging Market is anticipated to record a CAGR of 6.34% . Perfusion imaging is a non-invasive imaging test that demonstrates how the blood flows through the organs or tissues. This test is used for the diagnosis of various chronic disorders. Growing prevalence of cardiovascular & neurological diseases, rising geriatric population, and improvements in technology are pushing the growth of the global perfusion imaging market. However, stringent regulatory policies are prone to hinder the market growth. Growing incidence of cardiovascular & neurological diseases and increasing geriatric population are pushing the evolution of the global perfusion imaging market. As, as per the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, in the year 2017, every year about 795,000 people in the US have a hit in which about 610,000 of them are first, or new strokes and185,000 are recurrent strokes. Furthermore, innovations in technology are further stimulating market growth. In the year 2019, January Shimadzu Corporation bought Core Medical Imaging, Inc. to improve its healthcare business in North America. This procurement boosted the company’s foothold in the North American market. In March, 2018 GE received approval from Health Canada for Signa Premier, a 3.0T MRI system. This increased the product portfolio of the company. Australia held a share of 11.2% in the Asia-Pacific perfusion imaging market in 2018. Also, the market in the Middle East & Africa is expected to steadily grow owing to the increasing awareness about diseases in the region.
Market Segmentation:
Global Perfusion Imaging Market has been segmented by Modality, by application, and by region. Based on Modality the market is divided into Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI) and Nuclear Medicine. Based on application the market is divided into Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging, and Others. Based on region the market has been divided into various regions like Americas including US & Canada from North America and Latin America, Europe including Western Europe(Germany, UK, France, Italy, Spain, Rest of Western Europe and Eastern Europe), Asia-Pacific including China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific, and Middle East & Africa.
Regional Analysis:
The Global Perfusion Imaging Market has been distributed into several counties like Americas including US & Canada from North America and Latin America, Europe including Western Europe(Germany, UK, France, Italy, Spain, Rest of Western Europe and Eastern Europe), Asia-Pacific including China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific, and Middle East & Africa. The largest share of the global perfusion imaging market is expected to held by America.This is remaining to the rising rate of cardiovascular diseases, brain tumors, and tumor-related angiogenesis, among others, in the region. Europe showed a considerable amount of evolution in the market due to the rising prevalence of neurological disorders. Asia-Pacific is expected to be the quickest rising region in the global market due to the huge geriatric population and the presence of rapidly developing economies such as China, India, and South Korea.
Key Players:
The major companies functioning in the Global Perfusion Imaging Market are concentrating on firming their global ways by entering into untouched markets. Siemens (Germany), Bracco Diagnostic, Koninklijke Philips NV (Netherlands), lantheus Medical Imaging, Inc. (US), Shimadzu Corporation (Japan), Perimed (US), General Electric Company (US), Medtronic (Ireland), Inc. (Italy), Neusoft Corporation (China), Canon Medical Systems Corporation (Japan), Aetna (US), Advantis Medical Imaging (Netherland), and others are some of the major players in the Global Perfusion Imaging Market .The projected onlookers in the Global EMS and ODM Market are Hospitals Medical devices companies, Research institutes, Contract Research Organizations and Academic institutes.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
